Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LJ-001 shows broad-spectrum activity against virtually all enveloped RNA and DNA viruses. LJ001 inhibits the infection of transmissible gastroenteritis virus (TGEV) and porcine delta coronavirus (PDCoV).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 67.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 263.00 | |
25 mg | In stock | $ 538.00 | |
50 mg | In stock | $ 777.00 | |
100 mg | In stock | $ 1,090.00 | |
500 mg | In stock | $ 2,170.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 197.00 |
Description | LJ-001 shows broad-spectrum activity against virtually all enveloped RNA and DNA viruses. LJ001 inhibits the infection of transmissible gastroenteritis virus (TGEV) and porcine delta coronavirus (PDCoV). |
In vitro | In ST cells, LJ001 (12.5 µM) decreases the N-protein expression of TGEV and PDCoV and the gene mRNA expression in a time-dependent manner. LJ001 shows activities against HIV, HCV, influenza, Ebola, poxviruses and arenaviruses[3]. |
In vivo | In female BALB/c mice, oral gavage and intraperitoneal administration of LJ001 (20-50 mg/kg) shows no toxicity except a slight elevation in serum cholesterol levels[4]. |
Synonyms | LJ 001, LJ001 |
Molecular Weight | 327.42 |
Formula | C17H13NO2S2 |
CAS No. | 851305-26-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.27 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LJ-001 851305-26-5 Immunology/Inflammation Microbiology/Virology Proteases/Proteasome HIV Protease Antiviral LJ 001 LJ001 inhibitor inhibit